“…The onset of DOX-induced cardiomyopathy is characterized by several forms of tachycardia (Bristow, Minobe et al, 1981), altered left ventricular function (Hrdina, Gersl et al, 2000), and severe histological changes such as vacuolization of the cytoplasm, loss of myofibrils, altered sarcoplasmic reticulum, deposition of lipid droplets, and mitochondrial swelling (Lefrak, Pitha et al, 1973;Olson & Capen, 1978;Iwasaki & Suzuki, 1991;Sardao, Oliveira et al, 2009). More evidence suggests that mitochondria are a critical target in the development of DOX-induced cardiomyopathy (Yoon, Kajiyama et al, 1983;Praet & Ruysschaert, 1993;Jung & Reszka, 2001;Wallace, 2003;. Numerous mechanisms for the toxicity of DOX on cardiac mitochondrial function have been proposed, such as generation of free radicals (Muraoka & Miura, 2003), interaction with mitochondrial DNA (L'Ecuyer, Sanjeev et al, 2006), disruption of cardiac gene expression , alteration of calcium homeostasis (Lebrecht, Kirschner et al), lipid peroxidation mediating disturbance of mitochondrial membranes (Mimnaugh, Trush et al, 1985), and inhibition of mitochondrial respiration chain, decreasing both intracellular ATP and phosphocreatine (PCr) (TokarskaSchlattner, Zaugg et al, 2006).…”